INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

1,226 studies · page 6 of 52

2018 / Within-subject comparative study with washout

Diet restriction alone achieved similar short-term glycemic and insulin improvements as RYGB combined with the same diet in patients with type 2 diabetes.

Ten patients with type 2 diabetes completed a 10-day supervised peri-operative-equivalent diet intervention, followed by a washout period, and then an identical diet paired with RYGB. Both interventions produced similar improvements in glucose levels, β-cell function, insulin sensitivity, and post-meal hepatic insulin resistance, alongside significant decreases in fasting and postprandial acyl ghrelin. The diet-only period led to greater improvements in basal hepatic glucose output and post-meal GIP secretion, whereas the diet plus RYGB intervention induced significantly greater increases in post-meal GLP-1, PYY, and glucagon levels.

Pop LM, Mari A, Zhao TJ, et al. Diabetes Obes Metab, 2018. PMID 29532631

2018 / Double-blind, randomized crossover trial

TA-65 supplementation improved HDL-C, LDL/HDL ratio, BMI, waist circumference, and TNF-alpha in patients with metabolic syndrome.

A double-blind, randomized crossover trial evaluated the effects of 16 mg daily of TA-65 (an Astragalus membranaceus extract) versus placebo for 12 weeks with a 3-week washout in 40 patients with metabolic syndrome. Compared to placebo, TA-65 treatment led to significantly higher HDL-C and lower BMI, waist circumference, LDL/HDL ratio, and plasma TNF-alpha (p < 0.05 for all). Changes in HDL-C between periods were negatively correlated with changes in CRP (r = -0.511, p < 0.01), ALT (r = -0.61, p < 0.001), and TNF-alpha (r = -0.550, p < 0.001).

Fernandez ML, Thomas MS, Lemos BS, et al. Curr Pharm Des, 2018. PMID 29546832

2018 / Randomized controlled trial

A vegetarian diet reduced body creatine stores in women, without altering carnitine homeostasis.

Forty omnivorous women followed a control omnivorous diet, an unsupplemented vegetarian diet, or a vegetarian diet with creatine and beta-alanine for six months. Plasma and muscle total creatine dropped significantly by three months in unsupplemented vegetarians, whereas plasma creatine increased in supplemented vegetarians. Dietary changes did not affect carnitine-related measures or unsupplemented muscle carnosine, showing that low-dose creatine supplementation ameliorated the vegetarian-induced decline in the creatine pool.

Blancquaert L, Baguet A, Bex T, et al. Br J Nutr, 2018. PMID 29569535

2018 / Randomized clinical study

Dietary fibers selectively promoted gut bacteria producing short-chain fatty acids, improving HbA1c levels in patients with type 2 diabetes.

A randomized clinical study of specifically designed isoenergetic diets paired with fecal shotgun metagenomics evaluated the effect of dietary fibers in patients with type 2 diabetes mellitus. Dietary fibers selectively promoted a specific group of short-chain fatty acid (SCFA)-producing strains while diminishing or leaving unchanged most other potential producers. Greater diversity and abundance of these fiber-promoted SCFA producers led to greater improvements in hemoglobin A1c levels, partly through increased glucagon-like peptide-1 production, and diminished bacteria producing detrimental compounds like indole and hydrogen sulfide.

Zhao L, Zhang F, Ding X, et al. Science, 2018. PMID 29590046

2018 / 2 x 6-week randomized, double-blind, placebo-controlled crossover trial

Chronic nicotinamide riboside supplementation is well-tolerated and stimulates NAD+ metabolism in healthy middle-aged and older adults.

In a 2 x 6-week randomized, double-blind, placebo-controlled crossover clinical trial, researchers assessed the effects of chronic supplementation with the NAD+ precursor nicotinamide riboside (NR) in healthy middle-aged and older adults. Chronic NR supplementation was well tolerated and effectively stimulated NAD+ metabolism. The results suggest that future clinical trials should further evaluate the potential benefits of NR for reducing blood pressure and arterial stiffness in this population.

Martens CR, Denman BA, Mazzo MR, et al. Nat Commun, 2018. PMID 29599478

2018 / Validation study using data from a 2-year trial

The NIH Body Weight Planner accurately simulated average weight loss from calorie restriction, outperforming the PBRC Weight Loss Predictor.

Researchers compared two mathematical models underlying web-based weight-loss prediction tools (NIH BWP and PBRC WLP) against data from the 2-year CALERIE study of calorie restriction. The PBRC WLP model simulated an exaggerated early drop in energy expenditure, substantially underestimating observed mean weight loss by 3.8 (95% CI: 3.5, 4.2) kg. In contrast, the NIH BWP model showed much closer alignment with data, having an overall mean ΔBW bias of -0.47 (-0.92, -0.015) kg. However, both models exhibited substantial variability in simulating individual outcomes.

Guo J, Brager DC, Hall KD Am J Clin Nutr, 2018. PMID 29635495

2018 / Randomized crossover trial

Small doses of allulose modestly reduced postprandial glucose in type 2 diabetes.

In a double-blind, multiple-crossover trial of 24 adults with type 2 diabetes, adding 10 g of allulose to a 75-g glucose drink significantly reduced plasma glucose incremental AUC by 8% (717.4 ± 38.3 vs. 777.5 ± 39.9 mmol × min/L, P = 0.015) with a linear dose response. Reductions also occurred for secondary glucose metrics at 5 g and 10 g. Fructose showed no effect at any tested dose.

Noronha JC, Braunstein CR, Glenn AJ, et al. Diabetes Obes Metab, 2018. PMID 29797503

2018 / Controlled feeding trial

Excess saturated fat increased liver fat more than unsaturated fat or simple sugars

In a controlled clinical trial, 38 overweight adults received 1,000 extra kcal per day from saturated fat, unsaturated fat, or simple sugars for 3 weeks. Intrahepatic triglyceride levels increased by 55% with saturated fat and by 15% with unsaturated fat (P < 0.05), compared to 33% with simple sugars. Saturated fat overfeeding also elevated lipolysis, insulin resistance, endotoxemia, and plasma ceramides.

Luukkonen PK, Sädevirta S, Zhou Y, et al. Diabetes Care, 2018. PMID 29844096

2018 / Randomized crossover trial

A 4-day alkalizing diet significantly reduced 400-m sprint times compared with an acidizing diet in moderately trained adults.

Eleven recreationally active participants completed 400-m runs under their unmodified diet and after 4 days of an alkalizing (BASE) or acidizing (ACID) diet in a randomized crossover design. Participants had significantly lower 400-m performance times in the BASE trial (65.8 ± 7.2 s) compared with the ACID trial (67.3 ± 7.1 s; p = 0.026). Following the BASE diet, responses were also significantly higher for blood lactate (16.3 ± 2.7 vs 14.4 ± 2.1 mmol/L; p = 0.32 [as reported]) and urinary pH (7.0 ± 0.7 vs 5.5 ± 0.7; p = 0.001).

Limmer M, Eibl AD, Platen P J Int Soc Sports Nutr, 2018. PMID 29855319

2018 / Secondary analysis of two trials

Women following intermittent energy restriction showed spontaneous reductions in reported energy intake on unrestricted days.

Researchers analyzed self-reported food records from two trials of intermittent energy restriction (IER) in women (44 women for 6 months and 72 women for 4 months) to evaluate energy intake on unrestricted days. In both studies, reported energy intake on unrestricted days was 19% lower than the allocated isoenergetic diet, and 21% (Study 1) and 29% (Study 2) lower than baseline reported daily intakes, with similar reductions immediately before, after, and on other unrestricted days. Combined 3-month percentage weight loss was -5.8% (-6.7 to -4.7%) in those with consistent restriction days versus -7.4% (-8.7 to -6.2%) in the non-consistent group (p = .09). The authors noted that these findings need confirmation in larger groups, ideally using objective measures of energy balance.

Harvey J, Howell A, Morris J, et al. Food Sci Nutr, 2018. PMID 29876119

2018 / Randomized crossover trial

Small doses of fructose or allulose did not alter postprandial glucose in healthy adults.

A randomized crossover trial in 25 healthy adults assessed adding 0 g, 5 g, or 10 g of fructose or allulose to a 75-g oral glucose challenge. Neither sugar significantly changed plasma glucose incremental area under the curve or secondary glycemic markers. The authors noted the findings were limited by low statistical power stemming from greater than anticipated intra-individual variation.

Braunstein CR, Noronha JC, Glenn AJ, et al. Nutrients, 2018. PMID 29890724

2018 / Randomized crossover trial

Replacing milk with soymilk or calcium-fortified soymilk reduced postprandial serum phosphorus levels in healthy subjects.

Ten healthy subjects consumed three test meals containing milk, soymilk, or calcium-fortified soymilk with equal calcium to milk in a randomized crossover design. Blood was sampled up to 360 minutes and urine from 0 to 360 minutes post-meal. Serum phosphorus levels decreased the most after the soymilk meal and the least after the milk meal. Serum intact parathyroid hormone initially dropped and then gradually rose after each meal, with changes being more pronounced for soymilk than for milk or calcium-fortified soymilk.

Sakuma M, Suzuki A, Kikuchi M, et al. J Clin Biochem Nutr, 2018. PMID 29892166

2018 / Randomized controlled trial

Energy compensation was similar between 1,500 and 3,000 kcal/week of exercise, but 3,000 kcal/week was sufficient to decrease body fat.

Thirty-six overweight-to-obese sedentary adults were randomized to exercise expending 300 or 600 kcal/session, 5 days/week for 12 weeks (1,500 vs. 3,000 kcal/week). The 3,000 kcal/week group significantly decreased percentage and kilograms of body fat (P < 0.01), whereas the 1,500 kcal/week group did not. The 1,500 and 3,000 kcal/week groups compensated for 943 (95% CI: -164 to 2,050) and 1,007 (95% CI: 32 to 1,982) kcal/week (62.9% and 33.6% of exercise energy expenditure, respectively; P >= 0.93 between groups). Resting metabolic rate and energy intake did not change, while food reinforcement and glucagon-like peptide-1 decreased (P < 0.02) and acylated ghrelin increased (P <= 0.02).

Flack KD, Ufholz K, Johnson L, et al. Am J Physiol Regul Integr Comp Physiol, 2018. PMID 29897822

2018 / Controlled pilot trial

A 12-week ketogenic diet reduced fat mass and increased LDL cholesterol without affecting performance metrics in CrossFit trainees.

Twelve CrossFit trainees were divided into a ketogenic diet group (n = 7) or a normal-diet control group (n = 5) for 12 weeks while continuing their training. Blood beta-hydroxybutyrate levels were 2.8- to 9.5-fold higher in the ketogenic group, confirming nutritional ketosis. In the ketogenic group, DXA fat mass decreased by 12.4% (p = 0.053), vastus lateralis thickness decreased by ~8% (p = 0.065), and dual-leg lean mass decreased by 1.4% (p = 0.068), while LDL cholesterol increased by ~35% (p = 0.048). No significant between-group differences were found for total lean body mass, fasting glucose, HDL cholesterol, triglycerides, resting energy expenditure, 1-RM back squat, 400 m run times, or VO2peak.

Kephart WC, Pledge CD, Roberson PA, et al. Sports (Basel), 2018. PMID 29910305

2018 / Bioavailability study

Allicin bioavailability varies widely across different garlic supplements and foods.

In 13 human participants, allicin bioavailability or bioequivalence was measured across 13 garlic supplements and 9 garlic preparations using breath allyl methyl sulfide after ingestion. Enteric tablets showed 36% to 104% bioavailability, which fell to 22% to 57% with high-protein meals. Non-enteric tablets achieved 80% to 111%, while cooked garlic foods lacking alliinase activity still yielded unexpected bioavailability ranging from 16% to 66%.

Lawson LD, Hunsaker SM Nutrients, 2018. PMID 29937536

2018 / Randomized controlled trial

Ketogenic diet reduced fat mass but did not increase muscle during resistance training.

In an eight-week resistance training trial with caloric surplus, men consuming a ketogenic diet showed reduced fat mass (-0.8 kg, 95% CI -1.6 to -0.1) and visceral adipose tissue (-96.5 g, 95% CI -159.0 to -34.0). Neither total weight nor muscle mass increased significantly in the ketogenic group. Conversely, the non-ketogenic diet group gained both body weight (0.9 kg) and muscle mass (1.3 kg, 95% CI 0.5 to 2.2).

Vargas S, Romance R, Petro JL, et al. J Int Soc Sports Nutr, 2018. PMID 29986720

2018 / Randomized, placebo-controlled, double-blind parallel trial

In obese, insulin-resistant men, 12 weeks of nicotinamide riboside supplementation was safe but did not improve insulin sensitivity or glucose metabolism.

Forty sedentary, obese men aged 40-70 years were randomized to receive 12 weeks of nicotinamide riboside (NR, 1000 mg twice daily) or placebo. NR supplementation did not improve insulin sensitivity, endogenous glucose production, glucose disposal, or glucose oxidation. Furthermore, NR had no effect on resting energy expenditure, lipolysis, lipid oxidation, or body composition. No serious adverse events occurred and safety blood tests remained normal.

Dollerup OL, Christensen B, Svart M, et al. Am J Clin Nutr, 2018. PMID 29992272

2018 / Single-arm experimental feeding intervention

A high fruit and vegetable diet reduced the bone resorption marker CTX and increased the bone formation marker BAP in a 28-week feeding trial.

Twenty-nine participants underwent a 28-week single-arm feeding trial consisting of a 6-week low-fruit and vegetable diet (depletion-1), an 8-week high-fruit and vegetable diet, a second 6-week depletion, and an 8-week return to usual diet. Compared to baseline, depletion-1 increased serum CTX (from 0.68 to 0.97 ng/ml) and decreased BAP (from 10.7 to 9.5 µg/l; P<0.05). The high-fruit and vegetable diet subsequently reduced CTX to 0.60 ng/ml and increased BAP to 11.3 µg/l compared to depletion-1 (P<0.05).

Cao JJ, Whigham LD, Jahns L Br J Nutr, 2018. PMID 30022739

2018 / Cross-sectional single-blind before-and-after study

Mechanical removal of tongue coating significantly increased the perceived intensity of salty taste.

This single-blind study evaluated whether removing tongue coating altered salt taste perception in 90 participants. Salt taste intensity was evaluated using a drop of prepared tomato soup on the dorsal tongue surface before and after mechanical tongue cleaning, measured via a general Labeled Magnitude Scale (gLMS). Mean salt taste intensity increased significantly after tongue cleaning compared to before (p = 0.0002).

Seerangaiyan K, Jüch F, Atefeh F, et al. J Nutr Health Aging, 2018. PMID 30080223

2018 / Randomized 3x3 crossover trial

Adding Hass avocado to a meal lowered 3-hour GLP-1 AUC compared to control in overweight adults, while gut hormones correlated with appetite scores.

A randomized 3x3 crossover study in 26 healthy overweight adults evaluated gut hormone responses and appetite sensations across three lunch test meals consumed one week apart: control, isoenergic avocado inclusive, and energy increased avocado added (AA). A decrease in the 3-hour GLP-1 area under the curve was observed with the AA meal compared to the control meal (P = 0.03). Across meals, PYY3-36 and GIP were negatively associated with hunger, desire, and amount to eat, and positively associated with fullness, satisfaction, and composite visual analog scale (VAS) score (all P < 0.001). GLP-1 was negatively associated with hunger and positively associated with satisfaction and composite VAS score (all P < 0.05).

Haddad E, Wien M, Oda K, et al. Eat Behav, 2018. PMID 30096700

2018 / Phase 1 placebo-controlled study and observational analyses

In a phase 1 study, oral nicotinamide boosted circulating NAD+ metabolites, was well tolerated, and was associated with less acute kidney injury.

In critically ill patients, an elevated urinary quinolinate/tryptophan ratio predicted acute kidney injury (AKI) and other adverse outcomes. A phase 1 placebo-controlled study of oral nicotinamide (NAM) demonstrated a dose-related increase in circulating NAD+ metabolites. Oral NAM was well tolerated and was associated with less AKI. The study also examined murine models of AKI.

Poyan Mehr A, Tran MT, Ralto KM, et al. Nat Med, 2018. PMID 30127395

2018 / Double-blinded randomized controlled crossover trial

Oral taurine supplementation (2 g/day) reduced the frequency, duration, and severity of muscle cramps in patients with chronic liver disease.

In a double-blind, randomized crossover trial, patients with chronic liver disease and frequent muscle cramps received either oral taurine or placebo for 4 weeks before crossing over. Out of 49 enrolled patients, 30 completed the protocol and were included in the final analysis. Compared to placebo, supplementation with 2 g taurine/day led to fewer cramps (7 fewer/fortnight, P = 0.03), reduced duration (89 minutes less/fortnight, P = 0.03), and reduced severity (1.4 units less on a Likert scale, P < 0.004). Oral taurine significantly increased serum taurine levels (P < 0.001) without adverse side effects.

Vidot H, Cvejic E, Carey S, et al. Aliment Pharmacol Ther, 2018. PMID 30136291

2018 / Two-period intervention study

Blueberry supplementation increased VO2 max and exercise performance time while lowering post-exercise IL-6 and CRP levels in young active participants.

Eight young active participants were tested during a non-supplemented period and a blueberry-supplemented period to assess performance and biomarkers. VO2 max and exercise performance time increased in the blueberry supplementation period. Additionally, IL-6 and CRP levels were significantly lowered following exercise during the supplementation period.

Park CH, Kwak YS, Seo HK, et al. Iran J Public Health, 2018. PMID 30186809

2018 / Randomised, placebo-controlled, crossover study

Curcumin, alone or with fish oil, significantly reduced postprandial glucose and insulin responses in healthy individuals.

A randomised, placebo-controlled, crossover trial examined the effects of a single dose of placebo, curcumin (180 mg), fish oil (1.2 g LC n-3 PUFA), or curcumin plus fish oil before a standard meal in 16 healthy participants across 4 test days. At 60 minutes, postprandial glucose was significantly lower with curcumin (60.6%, P = 0.0007) and curcumin plus fish oil (51%, P = 0.002). Compared to placebo, blood glucose AUC was reduced by curcumin (36%, P = 0.003) and curcumin plus fish oil (30%, P = 0.004), but not fish oil alone (P = 0.105). Postprandial insulin AUC was also significantly reduced by 26% with both curcumin (P = 0.01) and curcumin plus fish oil (P = 0.03).

Thota RN, Dias CB, Abbott KA, et al. Sci Rep, 2018. PMID 30209353